Sarepta's (SRPT) "Products Offer Significant Upside" - William Blair Reiterates Stock at Outperform
Tweet Send to a Friend
William Blair analyst Tim Lugo reiterated an Outperform rating on Sarepta Therapeutics (NASDAQ: SRPT), following the company's latest quarterly report.The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
